Abstract
Ovarian stimulation is one of the fundamental pillars on which the treatment of in vitro fertilization is based The biopharmaceutical company Ferring has proposed the posology of recombinant FSH in an individualized manner according to the levels of anti-Mulleriana hormone in blood and body weight
Highlights
Ovarian stimulation is one of the fundamental pillars on which the treatment of in vitro fertilization is based
Monoclonal antibody marked with ruthenium kalate forming a sandwich complex
The reagent to be evaluated is anti-Mülleriana hormone (AMH) plus from Roche Diagnostics. It is composed of streptavidin-coated microparticles (M), mouse anti-AMH monoclonal biotinylated antibodies (R1) and mouse anti-mouse AMAM monoclonal antibody labeled with ruthenium (R2) chelate
Summary
Ovarian stimulation is one of the fundamental pillars on which the treatment of in vitro fertilization is based. It is not yet fully clear what parameters can help us achieve an adequate ovarian response [1,2,3]. The anti-Mülleriana hormone (AMH) has been proposed by several authors as a useful indicator when predicting the ovarian response, as well as being a marker that can guide as to the dose of gonadotropins is concerned [4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
